MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-06-0010246
Satyadeeptha Pharmaceuticals Limited - pharma in Humnabad, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹138.74 Cr
▼ 31% YoY
Net loss · FY 2025
₹75.5 Lakh
Net margin -0.5%
EBITDA · FY 2025
₹13.64 Cr
EBITDA margin 9.8%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.88 Cr
Issued & subscribed
Open charges
₹145.63 Cr
Satisfied ₹52.48 Cr
Company age
39 yrs
Est. 1987
Employees · EPFO
166
Provident fund records
About Satyadeeptha Pharmaceuticals Limited
Data last updated:
Satyadeeptha Pharmaceuticals Limited is a public limited company based in Humnabad, Karnataka, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 10 March 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85110KA1993PLC013900. Its GSTIN is 29AADCS9259B1Z4 (Karnataka). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.88 Cr. It was formerly known as Gladwin Pharmaceuticals Limited. It is led by directors including Surapaneni Ramakrishna (Managing Director) and Surapaneni Janardhana Rao (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.101A 101B 101P1 & 100P4 Industrial Development Area, Humnabad, Karnataka, India – 585330.
As per the financials filed for FY 2025, the company reported a revenue of ₹138.74 Cr, a decline of 31% compared to the previous year. For the same year it recorded a net loss of ₹75.5 Lakh (net margin -0.5%) and EBITDA of ₹13.64 Cr (EBITDA margin 9.8%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 4% over five years.
The company has about 166 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Satyadeeptha Pharmaceuticals. As per MCA filings, the company has open charges of ₹145.63 Cr and satisfied charges of ₹52.48 Cr on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it; 1 case is pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹3.83 Cr; the latest was in September 2022. Its 8 peer companies in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Azico Biophore India Private Limited with revenue of ₹140.48 Cr.
Satyadeeptha Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-06-0010246). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website satyadeeptha.com.
Company details
CIN U85110KA1993PLC013900
Registration Number 013900
Incorporation Date 10 March 1987
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KR-06-0010246
CIN history
Satyadeeptha Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231KA1993PLC013900. The current CIN is U85110KA1993PLC013900, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110KA1993PLC013900 | Current |
| U24231KA1993PLC013900 | Previous |
Key People
Surapaneni Ramakrishna Managing Director Surapaneni Janardhana Rao Whole-Time Director Surapaneni Sarojinidevi Whole-Time Director Recognitions & Rankings of Satyadeeptha Pharmaceuticals
Contact details
Satyadeeptha Pharmaceuticals Limited's registered office is in Humnabad, Karnataka. Its website is satyadeeptha.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.101A 101B 101P1 & 100P4 Industrial Development Area, Humnabad, Karnataka, India – 585330
- IndustryPharma, API Manufacturers
To see the full contact details of Satyadeeptha Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Satyadeeptha Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Satyadeeptha Pharmaceuticals operates one associated brand: Satyadeeptha Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures high-quality API and pharmaceutical products for various applications. | satyadeeptha.com |
Business activity
The main business activity of Satyadeeptha Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Satyadeeptha Pharmaceuticals Limited, buy the company report.
Financials of Satyadeeptha Pharmaceuticals Limited
FY 2025 filings availableSatyadeeptha Pharmaceuticals Limited reported revenue of ₹138.74 Cr (down 31% YoY) for FY 2025.
Revenue · FY 2025
₹138.74 Cr ▼ 31%
Net loss · FY 2025
₹75.5 Lakh margin -0.5%
EBITDA · FY 2025
₹13.64 Cr margin 9.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 31%
3 years · compounded
▲ 11%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▼ 30%
3 years · compounded
▲ 4%
5 years · compounded
▼ 9%
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 31% fall in the latest year. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.64 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹75.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | ||||
| Net Profit Margin | -0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Satyadeeptha Pharmaceuticals Limited, buy the company report.
Board of directors of Satyadeeptha Pharmaceuticals Limited
Satyadeeptha Pharmaceuticals has 6 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prasada Rao Kalluri Also directs: Genesis Ibrc India Limited, Cresto Techno Limited, Silly Monks Entertainment Limited and 4 more | Director | 25 Sep 2021 | 5 Years 1 Months | Current |
| Surapaneni Janardhana Rao | Whole-Time Director | 24 Feb 2023 | 3 Years 8 Months | Current |
| Surapaneni Sarojinidevi | Whole-Time Director | 20 Mar 1999 | 27 Years 7 Months | Current |
| Sudheer Kumar Aleti Also directs: Drill Tech Mining Solutions Private Limited, KMV Projects Limited, Abbotsburry Business Services Private Limited and 1 more | Director | 30 Sep 2025 | 1 Years 1 Months | Current |
| Surapaneni Ramakrishna | Managing Director | 18 Jan 1993 | 33 Years 9 Months | Current |
| Mandapakala Neelalohita | Director | 30 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Satyadeeptha Pharmaceuticals Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Azico Biophore India Private Limited | ₹140.48 Cr (FY 2024) | 25.0% | Hyderabad, Telangana, India | |||
| Midas Care Pharmaceuticals Pvt Ltd | ₹139.99 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Silicon Life Sciences Private Limited | ₹139.2 Cr (FY 2020) | 31.0% | Hyderabad, Telangana, India | |||
| Ontop Pharmaceuticals Private Limited | ₹138.93 Cr (FY 2024) | 4.0% | Hosur Road, Bangalore, Karnataka, India | |||
| Satyadeeptha Pharmaceuticals Limitedthis company | ₹138.74 Cr (FY 2025) | -₹75.5 Lakh | -0.5% | -31.0% | 166 | Humnabad, Karnataka, India |
| Atul Bioscience Limited | ₹136.8 Cr (FY 2025) | 3.0% | Atul, Gujarat, India | |||
| Lasa Laboratory Private Limited | ₹136.67 Cr (FY 2016) | 92.0% | Badlapur, Maharashtra, India | |||
| Corvine Chemicals and Pharmaceuticals Private Limited | ₹136.26 Cr (FY 2025) | 10.0% | Bidar, Karnataka, India | |||
| Kinvan Private Limited | ₹135.98 Cr (FY 2025) | 11959.0% | Solan, Himachal Pradesh, India |
To see the full peer comparison of Satyadeeptha Pharmaceuticals Limited, buy the company report.
Auditor
Satyadeeptha Pharmaceuticals Limited is audited by NGK & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NGK & ASSOCIATES | FY 2023 | 011224S |
Shareholding
The shareholding of Satyadeeptha Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Satyadeeptha Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹145.63 Cr
Satisfied charges
₹52.48 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 May 2025 | 101114157 | Others | ₹20 Cr | Open | |
| 11 Nov 2022 | 100671466 | Hdfc Bank Limited | ₹1.5 Cr | Open | |
| 07 Oct 2022 | 100643218 | Hdfc Bank Limited | ₹2.26 Cr | Open | |
| 07 Oct 2022 | 100643215 | Hdfc Bank Limited | ₹4.52 Cr | Open | |
| 05 Jan 2022 | 100520218 | Canara Bank | ₹3.2 Cr | Open |
To see the full charge records of Satyadeeptha Pharmaceuticals Limited, buy the company report.
Total charge records: 24 View all charges
Deals & funding
Satyadeeptha Pharmaceuticals Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹3.83 Cr; the latest was in September 2022.
Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹3.83 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2013 | Funding round | ₹3.83 Cr | Investors: 4 individuals |
| Jul 2007 | Secondary share transfer | Undisclosed | Buyer: S Rama Krishna HUF, 3 individuals Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Satyadeeptha Pharmaceuticals Limited has 8 court cases on record: 2 filed by Satyadeeptha Pharmaceuticals, 6 filed against it. 1 case is pending and 7 are disposed.
Total cases
8
Filed by the company
2
Filed against the company
6
Pending
1
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 6 | 0 |
| High courts | 2 | 0 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed against the company by Paushak Limited Through Authorized Person of Company Niyoti Patel | Disposed |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Paushak Limited Through Authorized Person of Company Niyoti Patel | Disposed |
| High Court of Karnataka | Writ petition | Filed by the company against The Karnataka State Pollution | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by M/S Bharat Jyoti Impex Through Ranjay Pandurang Patil | Disposed |
| District court, BIDAR, Karnataka | Criminal complaint | Filed against the company by an individual | Disposed |
To see the full case history of Satyadeeptha Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Satyadeeptha Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Satyadeeptha Pharmaceuticals Limited has a workforce of 166 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
166
Active EPFO establishments
1
Employee growth
2.47%
GST
Satyadeeptha Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCS9259B1Z4 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Satyadeeptha Pharmaceuticals Limited, buy the company report.
Recent activity
Satyadeeptha Pharmaceuticals Limited has 14 board changes on record since 1993: 6 appointments and 8 cessations. The latest: Mandapakala Neelalohita was appointed as Director on 30 Sep 2025.
Charges
A charge registered on 22 Apr 2021 via Charge ID 100437986 with Canara Bank was fully satisfied on 15 Oct 2025.
AGM
Satyadeeptha Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Mandapakala Neelalohita was appointed as Director.
Ceased
Nageswara Rao Balusupati ceased to be Director.
Ceased
Srinivasarao Bolla ceased to be Director.
Appointed
Sudheer Kumar Aleti was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 52.00 Cr registered on 01 Mar 2021 with Charge ID 100436435 was modified on 09 Jun 2025.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101114157 was registered on 12 May 2025.
Filing
Satyadeeptha Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with Hdfc Bank Limited of Rs. 4.52 Cr registered on 07 Oct 2022 with Charge ID 100643215 was modified on 29 Apr 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 2.26 Cr registered on 07 Oct 2022 with Charge ID 100643218 was modified on 26 Apr 2023.
Appointed
Surapaneni Janardhana Rao was appointed as Whole-Time Director.
53 earlier events are in the company report.
Frequently asked questions
Satyadeeptha Pharmaceuticals is an active public limited company based in Humnabad, Karnataka, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 10 March 1987 (39+ years old) and is registered under CIN U85110KA1993PLC013900.
Satyadeeptha Pharmaceuticals has 6 current directors:
- Surapaneni Ramakrishna - Managing Director
- Surapaneni Janardhana Rao - Whole-Time Director
- Surapaneni Sarojinidevi - Whole-Time Director
- Prasada Rao Kalluri - Director
- Sudheer Kumar Aleti - Director
- Mandapakala Neelalohita - Director
The latest financial statements of Satyadeeptha Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Satyadeeptha Pharmaceuticals is 29AADCS9259B1Z4, registered in Karnataka. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Satyadeeptha Pharmaceuticals is U85110KA1993PLC013900. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Satyadeeptha Pharmaceuticals has 8 court cases on record: 2 filed by the company and 6 filed against it. 1 is pending. Most are in the district courts.
Satyadeeptha Pharmaceuticals was incorporated on 10 March 1987, making it 39+ years old. It is registered with the Registrar of Companies, Bangalore.
Satyadeeptha Pharmaceuticals has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹3.83 Cr; the latest was in September 2022.
The peers of Satyadeeptha Pharmaceuticals by revenue are Azico Biophore India Private Limited, Midas Care Pharmaceuticals Pvt Ltd, Silicon Life Sciences Private Limited, Ontop Pharmaceuticals Private Limited, Atul Bioscience Limited and 3 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mandapakala Neelalohita was appointed as Director on 30 Sep 2025. Nageswara Rao Balusupati ceased to be Director on 30 Sep 2025. Srinivasarao Bolla ceased to be Director on 30 Sep 2025. Satyadeeptha Pharmaceuticals has 14 board changes on record in total.
Yes, Satyadeeptha Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-06-0010246).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages